Co-expression network analysis identified candidate biomarkers in association with progression and prognosis of breast cancer.
Qiang ZhouJiangbo RenJinxuan HouGang WangLingao JuYu XiaoYan GongPublished in: Journal of cancer research and clinical oncology (2019)
AGO2, CDC20, CDCA5, MCM10, MYBL2, and TTK were identified as candidate biomarkers for further basic and clinical research on breast cancer based on co-expression analysis.